← Leaderboards
Adam Matthew Beitz
Massachusetts Institute Of Technology
$189,169
Attributed
$189,169
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $91K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$189,169 · 2
By mechanism
F99$98,168 · 1
K00$91,001 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Ron Weiss$31,520,766
- Jefferson Matthew Taliaferro$4,015,549
- Daniela M Dinulescu$2,065,033
- Gregory Stephanopoulos$6,415,740
- Linda G. Griffith$21,069,415
Others in their field
Other Rising Stars on “Attention”
- John Alam · Eip Pharma, Inc.$10,411,018
- Joseph P. Uberti · Wayne State University$5,297,337
- Kathy Chapman · Westat, Inc.$4,702,179
- Jennifer Lee O'Brien · University Of South Florida$4,604,476
- Philip J. Norris · Vitalant$4,595,382
- Brian Smith · Case Western Reserve University$4,207,113
Research focus
AttentionBackBehaviorBindingBypassCancer InitiationCancer ModelCancerousCarcinogenesisCell Differentiation ProcessCell FractionCell ReprogrammingCellsCell SeparationCell TypeDesignDiagnosisDna Binding DomainEarly DiagnosisEctodermEffective TherapyEndodermEngineeringAdopted
Grant awards (3)
Mapping p53 dynamics to cell-fate outcomes in reprogramming and oncogenesis$91,001
K00 · FY2025 · CA · contact PI
Mapping p53 dynamics to cell-fate outcomes in reprogramming and oncogenesis$48,974
F99 · FY2024 · CA · contact PI
Mapping p53 dynamics to cell-fate outcomes in reprogramming and oncogenesis$49,194
F99 · FY2023 · CA · contact PI